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Abstract—Ischemic stroke is a leading cause of death and disability worldwide, so adequate prevention strategies
are crucial. However, current stroke risk stratification is based on epidemiologic studies and is still suboptimal
for individual patients. The aim of this systematic review was to provide a literature overview on the feasibility
and diagnostic value of vascular shear wave elastography (SWE) using ultrasound (US) in (mimicked) human
and non-human arteries affected by different stages of atherosclerotic diseases or diseases related to atheroscle-
rosis. An online search was conducted on Pubmed, Embase, Web of Science and IEEE databases to identify stud-
ies using US SWE for the assessment of vascular elasticity. A quality assessment was performed using Quality
Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) checklist, and relevant data were extracted. A total of
19 studies were included: 10 with human patients and 9 with non-human subjects (i.e., [excised] animal arteries
and polyvinyl alcohol phantoms). All studies revealed the feasibility of using US SWE to assess individually stiff-
ness of the arterial wall and plaques. Quantitative elasticity values were highly variable between studies. How-
ever, within studies, SWE could detect statistically significant elasticity differences in patient/subject
characteristics and could distinguish different plaque types with good reproducibility. US SWE, with its unique
ability to assess the elasticity of the vessel wall and plaque throughout the cardiac cycle, might be a good candi-
date to improve stroke risk stratification. However, more clinical studies have to be performed to assess this
technique’s exact clinical value. (E-mail: Judith.Pruijssen@radboudumc.nl) © 2020 The Author(s). Published
by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology. This is an open access
article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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INTRODUCTION
Worldwide, 13.7 million people experience a stroke each
year; it is the second leading cause of death and disability
(Global Burden of Disease Study [GBDS] Collaborators
2019). Approximately 80% of all strokes are ischemic
(GBDS Collaborators 2019), and 10%20% of ischemic
strokes are caused by carotid artery atherosclerosis (Flaherty
et al. 2013). To reduce the (recurrent) ischemic stroke risk, a
carotid endarterectomy (CEA) is performed, based mainly
on age, comorbidity, presence of neurologic symptoms, and
detection of a stenosis of the ipsilateral carotid artery>70%
by duplex ultrasound or computed tomography angiography
(CTA) (Chaturvedi et al. 2005). However, this selection
based on degree of stenosis is not perfect because, for steno-
ses>70%, on average only one stroke is prevented for each
six patients undergoing a CEA (Chaturvedi et al. 2005).
This is considerable because it is a rather risky procedure
given its peri-operative risk of stroke or death of 3%8%
(Chaturvedi et al. 2005).
To improve risk stratification, research interest has
shifted from degree of stenosis to plaque stability and
vulnerability because of increased evidence that non-ste-
notic, unstable atherosclerotic plaques are more vulnera-
ble to embolization, regardless of degree of stenosis
(Freilinger et al. 2012). Additionally, many patients with
a high degree of stenosis seem to have a low risk of pla-
que rupture (Horie et al. 2012). On the basis of patho-
logic features, plaques are classified as vulnerable or
stable, and are likely and unlikely to rupture, respec-
tively. Vulnerable plaques are defined by a large lipid-
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rich core separated from the lumen by a thin fibrous cap
infiltrated with active inflammation, so called thin-cap
fibroatheromas. Stable plaques are typically composed
of a fibrous core and thick fibrous cap (Spagnoli et al.
2004; Fisher et al. 2005).
To implement pathologic features in the risk stratifi-
cation before surgery, image-based studies have focused
on their non-invasive assessment. Currently, magnetic
resonance imaging (MRI) is the gold standard in the
assessment of carotid plaque vulnerability because of its
high sensitivity in detecting histologic features associ-
ated with vulnerability, but it is hindered by time con-
straints, contraindications and costs (Brinjikji et al.
2015), and has a limited resolution of 0.7 mm (isotropic)
in vivo using dedicated coils (Coolen et al. 2016). This
resolution limits the determination of individual plaque
components, especially in case of a mild (<50%) carotid
artery stenosis, the rupture of which is also considered to
cause a substantial proportion of strokes (Coutinho et al.
2016). In contrast, ultrasound is a cost-effective tech-
nique to assess stenosis degree, plaque morphology and
plaque characteristics that is already widely incorporated
in stroke risk assessment (Brinjikji et al. 2015), and has
at least a two times better resolution than MRI. Addi-
tional parameters have also been studied using ultra-
sound, and symptomatic ischemic strokes were
associated with an increased carotid intimamedia
thickness (IMT), plaque neovascularity, ulceration,
echolucency (gray-scale median [GSM]), and intrapla-
que motion (Brinjikji et al. 2015). Although these param-
eters are based on the pathologic features described
above, ultrasound techniques capable of directly assess-
ing mechanical plaque properties are still missing in
daily clinical practice.
Ultrasound elastography is an emerging technique that
directly quantifies plaque mechanics, that is, tissue stiffness,
and is therefore a potential candidate tool in the assessment
of plaque vulnerability. Elastography includes both strain
imaging and shear wave elastography (SWE) (Bamber et al.
2013; Hansen et al. 2016). In SWE an acoustic radiation
force push pulse, the so-called acoustic radiation force
impulse (ARFI) push pulse, is used to induce a shear wave
(Sarvazyan et al. 1998). This shear wave propagates perpen-
dicular to the push pulse and can be imaged while it
propagates through the tissue using ultrafast plane wave
acquisitions. The velocity by which it propagates is directly
related to the tissues’ elasticity expressed by the Young’s
modulus (YM) (Bamber et al. 2013). The stiffer the tissue,
the higher is the YM, and the higher is the shear wave veloc-
ity (SWV). Because YM is significantly lower for fatty tissue
than for fibrotic tissue (Chai et al. 2013), SWE is a potential
candidate tool to improve vulnerable plaque detection and,
therefore, to improve stroke risk stratification.
For large linearly elastic tissues, every frequency
component of the shear wave propagates at the same speed.
Because of this independence of frequency, the velocity of
the shear wave front can be tracked as a whole, providing
the group SWV (Graff 1991). This so-called group velocity
analysis is performed in all current commercial SWE devi-
ces, Therefore, we are referring to the group SWV when
we refer to SWV in this article. In heterogeneous, thin and
anisotropic material such as arteries, the assumptions made
by the clinical scanners are not entirely valid. The fre-
quency components of the induced waves propagate with
(slightly) different velocities, a phenomenon called disper-
sion. To account for dispersion, so-called phase velocity
analysis can be performed; that is, velocity is assessed per
frequency (Graff 1991). Models describing dispersion can
then be fitted to these phase velocities to obtain an estimate
of the YM (Couade et al. 2010; Bernal et al. 2011).
The aim of this systematic review was to provide an
overview of the available literature on the feasibility and
diagnostic value of using vascular SWE in (mimicked)
human and non-human arteries affected by different stages of
atherosclerotic diseases or diseases related to atherosclerosis.
METHODS
Search strategy and study selection
To retrieve all available studies on the vascular appli-
cation of SWE in atherosclerotic diseases, an online litera-
ture search was performed in Pubmed, Web of Science,
Cochrane library, Embase and IEEE databases on March
25, 2020. This search was based on three key words: Shear
wave elastography, Ultrasound, and Atherosclerosis. As an
example, the entry terms for the PubMed search, combined
by “AND,” are listed in Table 1. The same synonyms were
used in the remaining databases. Two authors independently
Table 1. Entry term searches
Key word MeSH term Free text entry term
Ultrasound “ultrasonography” echograph*[tiab] OR ultrasound[tiab] OR sonograph*[tiab] OR verasonic*[tiab]
OR supersonic*[tiab]
Atherosclerosis “atherosclerosis” OR “plaque,
atherosclerotic”
plaque*[tiab] OR fatty streak*[tiab] OR atheroscleros*[tiab]
OR arterioscleros*[tiab]
Shear wave elastography “elasticity imaging techniques” shear wave*[tiab] OR shear wave elastograph*[tiab] OR shear modul*[tiab]
OR elastic modul*[tiab] OR shear imaging[tiab]
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reviewed all titles and abstracts for eligibility. Subsequently,
the same authors retrieved full texts of potentially relevant
articles for further evaluation. Additionally, they conducted
a manual selection of potentially eligible studies from the
reference lists of included studies. Inclusion was based on
the following criteria: (i) English language, (ii) in vivo, ex
vivo or in vitro phantom studies involving or mimicking
arteries with atherosclerotic disease or diseases related to
atherosclerosis using ultrasound SWE, and (iii) assessment
of YM or SWV. Exclusion was based on the following cri-
teria: (i) editorials, (ii) reviews, (iii) letters to the editor, (iv)
case reports on fewer than five patients, (v) articles on math-
ematical optimization of SWE, (vi) articles not using SWE
to assess elasticity, and (vii) in case of in vivo studies, no
informed consent from each study participant and protocol
approval by an ethics committee or institutional review
board (human studies) or institutional animal care and use
committee (animal studies) mentioned. When the two
reviewers did not agree, a third reviewer was consulted to
decide on inclusion or exclusion.
Data extraction and quality assessment
After inclusion, one author systematically extracted
relevant data regarding each publication, pre-defined as (i)
year of publication, (ii) country of research, (iii) number of
included patients, (iv) subject characteristics (i.e., for
humans, age and sex; for animals, imaged artery; for phan-
toms, percentage of polyvinyl alcohol [PVA] and number
of freezethaw cycles), (v) imaging characteristics (i.e.,
type of ultrasound system and probe, imaging and push fre-
quency, push duration, push location and scan direction),
(vi) reference standard, (vii) use of electrocardiogram
(ECG) gating, (viii) values of SWV/YM/shear modulus
and (ix) most important results (e.g., correlations of YM
and plaque characteristics or accuracy). Quality assessment
of human studies was performed by one author using the
Quality Assessment of Diagnostic Accuracy Studies 2
(QUADAS-2) checklist (Whiting et al. 2011), a standard-
ized and validated tool used to assess quality and risk of
bias of diagnostic accuracy studies. Because non-human
studies do not match criteria of a standardized checklist,
qualitative assessment of these studies was not performed.
Conference abstracts and proceedings were individually
analyzed, and additional items that are not discussed in the
included full articles are stated in the Results because they




A flowchart of data selection is provided in Appen-
dix A (online only, see Supplementary Data). With the
initial database search and reference evaluation, 838
individual studies were identified. 45 published articles
were selected based on title and abstract and further
screened on full-text reading. 26 articles were excluded
for reasons stated in Appendix A (online only, see Sup-
plementary Data). Eventually, 19 published articles were
included for qualitative assessment and data extraction.
These studies were divided according to the subjects
involved: human subjects or non-human subjects (i.e.,
[excised] animal arteries or phantoms). Extracted data
for human and non-human studies are listed in Tables 2
and 3, respectively. Eighteen conference abstracts and
seven proceedings were selected based on title and
abstract. After screening for publication of these studies,
respectively 11 and 2 conference abstracts and proceed-
ings were included and further analyzed. Extracted data
for these studies are listed in Appendix B (online only,
see Supplementary Data). A meta-analysis was not con-
ducted because of the heterogeneity of study type, types
of patients included, methods and reported results.
Quality assessment
An overview of the qualitative assessment of
included human studies is provided in Appendix C
(online only, see Supplementary Data). All studies
scored an unknown or high risk of bias in at least one
category. Seven studies (Ramnarine et al. 2014b; Gar-
rard et al. 2015; Li et al. 2016; Zhang et al. 2016; Alis
et al. 2018; Shang et al. 2018; Marlevi et al. 2020) did
not report whether they included patients randomly or
consecutively, and one study reported they did not (Mar-
ais et al. 2019). In addition, most studies (Li et al. 2016;
Zhang et al. 2016; Lou et al. 2017; Marais et al. 2019)
did not report whether the index test was interpreted
without knowledge of the reference standard and vice
versa. Additionally, multiple studies (Ramnarine et al.
2014b; Zhang et al. 2016; Lou et al. 2017; Shang et al.
2018) used echogenicity as a reference standard in
assessment of plaque vulnerability. However, echogenic-
ity provides only an indication of plaque composition; it
does not absolutely assess it. Di Leo et al. (2018) did not
mention any quantitative values measured by the index
test, which complicates the assessment of whether its
interpretation could have introduced bias. Finally, two
studies (Ramnarine et al. 2014b; Shang et al. 2018) did
not include all patients in the final analysis because of
complete occlusion of the internal carotid artery (ICA)
and presence of both hyper- and hypo-echoic plaques on
the symptomatic side. Marais et al. (2019) also did not
include all patients in the final analysis but they argued
that the included subpopulation was representative of the
entire population. This minimizes the chance of bias
induced by patient flow. Overall, the main sources of
bias related to this review could be the selection of
patients and the use of echogenicity, which is not a gold
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Table 2. Characteristics of human studies included





Comparisony Mean SWV/YM*,z Most important findings
Marlevi et al.
2020
Sweden 20 + stress echocardi-
ography + plaques;
27 plaques
68 § 8 16 (80) General Electric Logiq E9,
L9 MHz probe; 4.1- or 5.0-






ity (L/T): V (n = 8):
4.0 § 1.1/3.3 §
0.7 m/s (YM: 50 §
4/34 § 2 kPa)
VI (n = 8): 5.8 §
0.6/7.3 § 2.5 m/s




T): V: 4.1 § 1.9/4.3
§ 1.4 m/s (YM: 52
§ 11/58 § 6);
VI: 7.0 § 1.4/5.2 §
2.1 m/s (YM: 153 §






Group and phase veloc-






















L8 MHz probe, FR 8 kHz;
3£ 100 ms; 3 depths 5 mm
apart in center ROI includ-









HT: 5.9 § 0.9/6.8 §
1.4 m/s (YM: 108.6




NT: 5.2 § 1.0/7.4 §









cycle, no difference in
NT and HT with similar
BP
SWV had good agree-





than SWV (20.5% vs.
8.3%, resp.)




NR NR Toshiba Aplio 500, L14-











AUC (SWE) = 76.9%,
AUC (CTA) = 93.5%
SWE had high agree-
ment with CTA (81.4%,
Cohen’s k = 0.58)





















































76 (54) Aixplorer (Supersonic), L15-






































Toshiba Aplio 500, L14-
7 MHz probe; NR; NR;
longitudinal
No# Healthy controls Wall (right/left): Beh-
cets disease: 3.72 §
0.94/3.57 §
0.72 m/s (YM: 34.2







Mean SWV higher in
right and left CCA in
patients than controls
SWV did not correlate
with cIMT
Lou et al. 2017 China 61+ plaques;
271 plaques**
66 § 8 45 (74) Aixplorer (Supersonic),







(n = 13): 70.74; 2
(n = 35): 78.83; 3
(n = 195): 129.80; 4
(n = 21): 118.75; 5







(n = 30): 115.78 §
26.66 kPa
SWV correlated with
GSM (lower SWV in
lower GSM)
Mean YM lower in
symptomatic than
asymptomatic patients
YM + SR best to predict
symptomatic plaques
AUC (YM) = 0.87,
AUC (YM + SR) = 0.93,
AUC (GSM) = 0.76
Perfect reproducibility
YM with SWE (inter-
frame CV = 16%)























































Comparisony Mean SWV/YM*,z Most important findings
Zhang et al.
2016
China 199 + plaques;
277 plaques
66 § 11 105 (53) Aixplorer (Supersonic), L10-









echoic (n = 137):
15.7 § 8.2/17.4 §
8.7/11.3 § 7.5 kPa
Hyper-echoic
(n = 140): 51.8 §
16.3/50.8 § 19.3/
56.6 § 17.0 kPa
YM lower in hypo- than
hyper-echoic plaques
YM values differ with
plaque site
YM lower in all plaques
in case of HT + hyper-
lipidemia/hyperlipid-
emia alone, YM also
lower in hypo-echoic
plaques in case of HT
Excellent reproducibil-








99 (57) Aixplorer (Supersonic), L15-










Mean, maximal, and SD
YM higher in AIS
patients than controls
(minimal equal)




Optimal YM cutoff val-
ues detected
AIS mean, maximal,
minimal and SD = 55.4,
65.4, 57.5 and 3.2 kPa
AUC PWV, mean YM
and max YM = 0.55 §
0.03, 0.59 § 0.03 and
0.60 § 0.03
High intra- and inter-
group reproducibility






76 § 9 16 (64) Aixplorer (Supersonic), L15-






(n = 9)yy: 50.0§
19.6 kPa;
Stable (n = 16):
79.1§33.8 kPa
Mean YM lower in unsta-
ble than stable plaques
YM lower for plaques
with histologic features
related to instabilityzz
YM not correlated with
GSM














































Comparisony Mean SWV/YM*,z Most important findings
Ramnarine
et al. 2014b
UK 81 + clinical carotid
US;
54 plaques
76 § 11 51 (63) Aixplorer (Supersonic), L15-












(n = 27): 62 § 6
kPa1;
Asymptomatic
(n = 20): 88 § 9
kPaxx;
GSM: 1 (n = 7): 20;
2 (n = 14): 35; 3
(n = 21): 42; 4
(n = 12): 63 kPa
YM correlated with GSM
in plaques (lower YM
in lower GSM)
YM lower in symptom-
atic than asymptomatic
plaques
YM lower at higher
degree of stenosis
YM not significantly
related to age in plaque
or vessel wall
YM + SR best to predict
symptomatic plaques
(AUC YM= 0.69,




(CV = 22% [vessel
wall] and 19% [plaque])
SWV = shear wave velocity; YM =Young’s modulus; ROI = region of interest; MRI = magnetic resonance imaging;AHA = American Heart Association; LRNC = lipid-rich necrotic core; IPH = intra-
plaque hemorrhage; HT = hypertension; NT = normotension; FR = frame rate; PWV = pulse wave velocity; NR = not reported; aSWV = anterior shear wave velocity; BP = blood pressure; pSWV = pos-
terior shear wave velocity; CEA = carotid endarterectomy; CTA = computed tomography angiography; AUC = area under the curve; CCA = common carotid artery; cIMT = carotid intimamedia
thickness; GSM = gray-scale median; SR = stenosis rate; CV = coefficient of variance; ICC = intraclass correlation coefficient; AIS = acute ischemic stroke; SD = standard deviation; LDL = low-density
lipoprotein; CVE = cerebrovascular event; US = ultrasound.
* Reported as § SD or, if not reported, as interquartile range.
y Boldface indicates the intended reference standard.
z Calculated as YM ¼ 3rc2, where r = tissue density in kg/m3 and c = SWV in m/s.
x Value not reported but YMs for soft, mixed, and hard plaques were 1125, 2665 and 65 kPa, respectively.
{ Defined as having one or more vulnerable features: fibrous cap <200 mm, lipid core, intraplaque hemorrhage, inflammatory infiltrate, or intraplaque neovascularization.
║ Defined as having caused focal neurologic symptoms relating to the ipsilateral brain hemisphere within the past 6-mo period.
# Although images were not ECG-triggered, SWV was measured in end diastole.
** In case of multiple plaques, the highest-risk plaque, based on the total plaque risk score (based on stenosis percentage, echogenicity, texture grade and surface characteristics) was identified as the
patient’s representative plaque.
yy Based on the American Heart Association histologic classification (Lovett et al. 2004).
zz Defined as hemorrhage/thrombus, fibrous tissue, large lipid core, foam cells.

















































Table 3. Characteristics of non-human studies included







ECG trigger Comparison Mean SWV/YM Most important findings
Marlevi et al.
2018
Sweden Ex vivo: 1 aorta







push, FR = 11.7







Plaque: 0.98.6 m/s (YM:
2.5230.8 kPa*), depen-
dent on speed met-
ric + image specification
Frequency bandwidth1 kHz
highest ability to differenti-
ate plaque stiffness
Phase velocity!YM
underestimation in low fre-
quency; accurate values




est ability to differentiate
plaque stiffness + lowest
speed deviation
SWVs invariant to push
location, but differences in
SNR + particle velocity
Longitudinal better ability
to differentiate plaques than
transverse
Shih et al. 2018 Taiwan Ex vivo: 1 abdominal
aorta (rabbit) with
plaque (lipid-rich
diet + FeCl3 injury)
Dual-frequency
IVUS, FR = 20 kHz;
2001000 ms; NR;
longitudinal
n/a n.a. Wall: 3.45 § 0.45 m/s (YM:
37.13 § 0.63 kPa*)
Plaque: 0.38 § 0.19 m/s
(YM: 0.45 § 0.11 kPa*)
IVUS SWE can distinguish
regions of different stiffness
SWE acoustic output in
vitro: max Ispta = 412.9 mW/
cm2 (within-safety limits in
FDA guideline:<720




In vitro: 2 phantoms
(gelatin 3% rod, 7%
wall + vice versa)
n/a n.a. 3% Gelatin: ca. 0.6 m/s (YM:
1.1 kPa*)
7% Gelatin: ca. 1.4 m/s
(YM: 6.1 kPa*)
Guo et al. 2018 China Ex vivo: 1 abdominal




5 MHz push, FR 8
kHz; 100 ms; ante-
rior wall;
longitudinal
n/a n.a. Wall: Longitudinal 50 kPa;
circular 150 kPa
SWE is able to quantify stiff-
ness in many directions, but
elasticity values differ with
detection angles so geome-
try correction is needed
In vitro: 3 homoge-
nous phantoms




NRy (MT: 100 kPa)
















































ECG trigger Comparison Mean SWV/YM Most important findings
He et al. 2017 China In vivo: 1 healthy
volunteer
Verasonics V1, L10-5
probe, 5 MHz push,
FR 14.7 kHz; 170
ms; center anterior
wall; transversal










rate elasticity values com-
pared with MT
A directional filter can
effectively filter out
reflected waves
Ex vivo: 1 abdominal
aorta (pig), no
plaque
n/a n.a. Wall: 2.6 m/s (YM: 21.1
kPa*)





Wall: phase velocity: 90 kPa
(MT: 89.1 § 3.6) kPa),















n/a n.a. Wall: 258§39 to 522§
105 kPa (p:20-120 mmHg)
2z
Plaque: 123§15 to 291§
30 kPa 2
SWE can measure stiffness in
ex vivo arteries with differ-
ent stiffness
Linear response in stiffness
with respect to BP
Frequency bandwidth
1.5 kHz needed for con-
sistent YM assessment
High PRF more important
than higher image quality
Maksuti et al.
2016
Sweden In vitro: 15 phantoms








probe, 5 MHz push,






Wall: phase velocity: 91.8 §
9.6; kPaz
Group velocity: 20.1 § 0.0
kPaz (MT: 91.5 § 1.2)
Dependent on pressure + F/
T cycles
Phase velocity! accurate
stiffness values in vessel
phantoms validated with MT
(relative error: 8.8§ 6.0%,
absolute error: 5.6§ 4.1 kPa)
Group velocity! inaccurate
elasticity values in vessel wall
Widman et al.
2015
Sweden In vitro: 6 phantoms
(3 soft, 3 hard pla-
que; wall: 10%






6 MHz push, FR 8






Wall: 75.0 § 3.6 kPaz (MT:
89.1 § 1.5)z
Plaque: soft 17.4 § 0.9
kPaz (MT: 9.9 § 1.5)z;
hard: 318.6 § 51.6 kPaz
(MT: 294.9 § 10.2 z
SWE can assess elasticity is
feasible in simulated car-
diac cycle
Phase velocity! good
agreement in plaque and
wall with MT (slight over-
and underestimation in
respective plaques and


































































UK In vitro: 3 phantoms
(1 homogenous, 1
hard, 1 soft plaque;
wall: 10% PVA,
5£ F/T; plaque:
soft: 5£ F/T; hard:








Wall: 35120 kPa depending
on pulse/homogeneity
Plaque: soft: 30130 kPa;
hard: 30260 kPa
Quantitative elasticity assess-
ment with SWE is feasible
in vessel wall + different
plaque models, even in the
presence of pulsatile flow
Good reproducibility YM
with SWE (mean inter-
frame CV 0.130.14 + ICC
0.830.84, mean interob-
server CV 0.13 + ICC 0.76)





kHz; 3£ 100 ms;
anterior wall;
longitudinal
Yes n.a. Wall (diastole/systole): 80 §
10/ 130 § 15 kPaz
Real-time + quantitative elas-
ticity assessment with SWE
is feasible
SWE acoustic output in
vivo: total Ispta = 630 mW/
cm2 (within FDA guide-
lines <720 [Guidelines for
Industry and FDA Staff
2008]) + no histologic
changes
Elastic properties vary dur-
ing the cardiac cycle
Frequency bandwidth
>1 kHz best to assess YM
in arterial application
Shear wave propagation is
very dispersive
In vivo: 10 CCAs
(sheep) (48 h after
death)
No Histology!safety Wall (early/late systole): 117
§ 48/173,519 § 77 kPaz
In vitro: 8 phantoms
(4 plates, 4 tubes,
2% and 4% agar §
background), no
plaque, pressurized
n/a Theoretical model NR
ECG = electrocardiogram, SWV = shear wave velocity, YM =Young’s modulus, PVA = polyvinyl alcohol, F/T = freezethaw cycle, FR = frame rate, SNR = signal-to-noise ratio, IVUS = intravascu-
lar ultrasound, NR = not reported; Ispta = spatial-peak temporal-average intensity, FDA = U.S. Food and Drug administration MT =mechanical testing, BP = blood pressure, PRF = pulse repetition fre-
quency, CV = coefficient of variance, ICC = intra-class correlation coefficient; CCA = common carotid artery.
* Calculated as YM ¼ 3rc2; where r = tissue density in kg/m3 and c = SWV in m/s.
y No value reported because in vitro measurements were aimed at defining the default caused by the measurement angle.








































standard, as a reference standard. However, in our opin-
ion, the concerns regarding the methodology of the
included studies do not limit their applicability to
answering the research question of this review.
Applied ultrasound techniques
The included studies used three different ultrasound
machines with different setups. Most studies used an
Aixplorer ultrasound system (Supersonic Imagine, Aix-en-
Provence, France). Two human studies used a Toshiba Aplio
500 system (Toshiba Medical Systems Co, Ltd, Tokyo,
Japan) and one used a General Electric Logiq E9 system
(GE Healthcare, Wauwatosa, WI, USA); four non-human
studies used a Verasonics system (Verasonics, Kirkland,
WA, USA). In all cases a linear array probe was used. In
human studies, push frequencies and imaging rates were not
reported, except for an imaging frame rate of 8 kHz by Mar-
ais et al. (2019). Marlevi et al. (2020) applied a dual-sided
push pulse of 400 ms simultaneously triggered in the left-
and right-hand sides of the region of interest (ROI). Marais
et al. (2019) applied three supersonic pushes of 100 ms at
three depths 5 mm apart along the centerline of the ROI,
including the anterior and posterior wall. Also, Marais et al.
were the only ones to compensate the location of shear wave
acquisitions for wall movements during the cardiac cycle
using the diameter values measured by echotracking. In the
remaining human studies, the clinical mode was used, with-
out a specification of push duration and push location.
In non-human studies, push pulse central frequency,
push duration and imaging frame rates ranged from
4.09 MHz (Widman et al. 2016; Marlevi et al. 2018) to
6 MHz (Widman et al. 2015), from 100 ms (Widman
et al. 2016; Guo et al. 2018) to 1000 ms (Shih et al.
2018), and from 8 kHz (Couade et al. 2010; Widman
et al. 2015; Maksuti et al. 2016; Guo et al. 2018) to
20 kHz (Shih et al. 2018), respectively. The push loca-
tion varied but was mostlypositioned in the anterior
wall.
A representative example of a frequently used
method of YM assessment with a commercial ultrasound
system (Aixplorer Supersonic Imagine) is the method of
Ramnarine et al. (2014b) with circular ROIs, as illus-
trated in Figure 1. A representative example of a state-
of-the-art non-commercially available implementation
of group and phase velocity analysis in the longitudinal
and cross-sectional imaging direction using raw ultra-
sound data is the method of Marlevi et al. (2020), illus-
trated in Figure 2.
SWE IN HUMAN PATIENTS
Study characteristics
The 10 studies on SWE in human carotid arteries
(Ramnarine et al. 2014b; Garrard et al. 2015; Maksuti
et al. 2016; Zhang et al. 2016; Lou et al. 2017; Alis et al.
2018; Di Leo et al. 2018; Shang et al. 2018; Marais et al.
2019; Marlevi et al. 2020) were performed with varying
numbers of patients, that is, 22 (Marlevi et al. 2020) to
199 (Zhang et al. 2016); different diseases affecting the
arterial wall, that is, Behçets disease (Alis et al. 2018)
and hypertension (Marais et al. 2019); and different
stages of atherosclerotic disease, that is, atherosclerotic
plaques (Ramnarine et al. 2014b; Zhang et al. 2016; Lou
et al. 2017; Marlevi et al. 2020), symptomatic patients
with a CEA scheduled (Garrard et al. 2015; Di Leo et al.
2018) or without a CEA scheduled (Maksuti et al. 2016;
Shang et al. 2018); and different methods of comparison,
that is, pulse wave velocity (PWV) (Maksuti et al. 2016;
Marais et al. 2019) and/or healthy controls (Ramnarine
et al. 2014b; Maksuti et al. 2016; Alis et al. 2018; Marais
et al. 2019) in the arterial wall, and plaque echogenicity
(GSM) (Garrard et al. 2015; Zhang et al. 2016; Lou et al.
2017; Shang et al. 2018), neurologic symptoms (Ram-
narine et al. 2014b; Lou et al. 2017; Shang et al. 2018),
histologic features (Garrard et al. 2015; Di Leo et al.
2018), American Heart Association (AHA) classification
of atherosclerotic plaques as assessed with MRI (Marlevi
et al. 2020), percentage stenosis (Ramnarine et al.
2014b) and/or other cardiovascular risk factors (Ramnar-
ine et al. 2014b; Maksuti et al. 2016; Zhang et al. 2016;
Shang et al. 2018; Marais et al. 2019) in arterial plaques.
Because not all patient groups present with atheroscle-
rotic plaques, three studies solely investigated the carotid
arterial wall (Maksuti et al. 2016; Alis et al. 2018; Mar-
ais et al. 2019). Only one study (Marais et al. 2019)
applied echocardiogram (ECG) gating, whereas in the
other studies, usually a 10-sec cineloop was recorded
and values were averaged over the middle four to five
recorded shear wave frames randomly distributed
throughout the cardiac cycle. Only Marlevi et al. (2020)
focused on SWE in the cross-sectional and longitudinal
imaging views whereas others investigated SWE only in
the longitudinal imaging view.
Feasibility and value
All studies reported the feasibility of using ultrasound
(US) SWE in carotid arteries and found statistically signifi-
cant differences in elasticity with patient characteristics in
both the arterial wall and plaques. In the carotid arterial wall,
SWV was higher throughout the entire cardiac cycle higher
in patients with hypertension compared with normotensive
controls. This difference disappeared when both groups
were compared at similar blood pressures (Marais et al.
2019). Behçet’s disease (Alis et al. 2018) was, independent
of blood pressure, associated with a higher SWV compared
with controls. In addition, stiffness values positively corre-
lated with patient characteristics (i.e., age, systolic blood
pressure and low-density lipoprotein) in patients with
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hypertension (Marais et al. 2019) and ischemic stroke (Mak-
suti et al. 2016).
In carotid artery plaques, stiffness values were sig-
nificantly lower in plaques with markers of vulnerability,
namely, in symptomatic compared with asymptomatic
plaques, where symptomatic plaques were defined as
having caused focal neurologic symptoms relating to
ipsilateral brain hemisphere within the past 6-month
period (Ramnarine et al. 2014b; Lou et al. 2017; Shang
et al. 2018); in histologically classified vulnerable pla-
ques compared with stable plaques, where vulnerability
was defined as having one or more vulnerable features
(among others, fibrous cap <200 mm, lipid core and
intraplaque hemorrhage) (Garrard et al. 2015; Di Leo
et al. 2018); in plaques classified as vulnerable with MRI
compared with all other plaque types, where vulnerable
plaques were defined as AHA type VI (Marlevi et al.
2020); and, except for the study of Garrard et al. (2015),
in hypo-echoic compared with hyper-echoic plaques
(Ramnarine et al. 2014b; Zhang et al. 2016; Lou et al.
2017; Shang et al. 2018). In addition, Ramnarine et al.
(2014b) found a lower YM in plaques in patients with a
higher degree of stenosis; and Zhang et al. (2016) found
a lower YM in patients with cardiovascular risk factors
(i.e., hyperlipidemia with or without hypertension) com-
pared with patients without these factors.
Quantitative stiffness values
Absolute SWE values vary widely among studies, but
within each study, quantitative SWE values significantly
differ with respect to patient and plaque characteristics.
Validation and reproducibility
SWE results were in good agreement with results of
other imaging techniques and had good to excellent repro-
ducibility. In the carotid arterial wall, SWE velocities were
Fig. 1. Example of quantitative stiffness assessment using a commercial ultrasound system (Aixplorer SuperSonic, Aix-
en-Provence, France) in a patient with a stenosis of 30%40% at the origin of the internal carotid artery. Left: B-Mode
image with the internal carotid artery (ICA) and common carotid artery (CCA). Right: Elastogram of the ICA and CCA
with six 2-mm circular regions of interest in the anterior (2) and posterior (4) CCA, the anterior (1) and posterior (3)
ICA, within the plaque (P1 and P2). (Reprinted with permission from Ramnarine et al. [2014b], published under the
terms of the Creative Commons Attribution License [http://creativecommons.org/licenses/by/4.0]).
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in good agreement with PWV (i.e., local carotid assessed
by US and global carotid-femoral assessed by tonometry
with Spearman’s correlation coefficients [r] of 0.56 and
0.66, respectively [Marais et al. 2019]) and had a good
reproducibility (interframe coefficient of variation [CV] of
22% [Ramnarine et al. 2014b]). However, comparison
between the anterior and posterior wall revealed a higher
variability in the posterior wall (interframe CV= 20.5% vs.
8.3% [Marais et al. 2019]).
In carotid artery plaques, SWEwas in good agreement
(81.4%, Cohen’s k = 0.54) with CTA in detection of histol-
ogy-based vulnerability with an equal, high, sensitivity of
87.1% but lower specificity (66.7 vs. 100%) (Di Leo et al.
2018). Reproducibility analysis in four studies (Ramnarine
et al. 2014b; Maksuti et al. 2016; Zhang et al. 2016; Lou
et al. 2017) revealed good to excellent agreement for pla-
ques located anywhere around the arterial wall circumfer-
ence (i.e., interframe CV of 16%19%) [Ramnarine et al.
2014b; Lou et al. 2017]).
SWE IN NON-HUMAN PATIENTS
Study characteristics
Nine of the included studies (Couade et al. 2010;
Ramnarine et al. 2014a; Maksuti et al. 2016; Widman
et al. 2015, 2016; He et al. 2017; Guo et al. 2018; Mar-
levi et al. 2018; Shih et al. 2018) performed SWE acqui-
sition in non-human patients (i.e., ex vivo animal studies
and/or in vitro phantom studies). Notably, multiple non-
human studies applied group and phase velocity analysis
in contrast to human studies that, except for one, applied
only group velocity. One study (He et al. 2017) included
imaging in the cross-sectional imaging view.
Feasibility and tolerability
All studies reported on the feasibility of using SWE
to (quantitatively) assess elasticity in a phantom vessel
wall and different plaque models, even during a simu-
lated cardiac cycle (Couade et al. 2010; Ramnarine et al.
Fig. 2. Example of group and phase velocity analysis in the longitudinal and cross-sectional imaging directions for one
American Heart Association (AHA) type VI and one AHA type VI plaque using the raw ultrasound data of a General
Electric Logiq E9 system (GE Healthcare, Wauwatosa, WI, USA). From left to right are B-mode images of the carotid
artery including the plaque, shear wave elastography (SWE) acquisition, ultrafast motion images obtained from data
autocorrelation (from upper left to lower right four snapshot motion images are displayed), axial velocity map (space-
time domain) with time-to-peak estimated group velocity (red slope) and Fourier-generated dispersion behavior and
phase velocity map (velocityfrequency domain). All examples are shown over a frequency range of 0750Hz.
(Reprinted with permission from Marlevi et al. [2020], published under the terms of the Creative Commons Attribution
License [http://creativecommons.org/licenses/by/4.0]).
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2014a; Widman et al. 2015, 2016). YM differences of at
least 4.8 kPa could be distinguished between different
phantom samples (Shih et al. 2018). Stiffness values var-
ied strongly during the cardiac cycle (Couade et al.
2010), whereby both a linear (Widman et al. 2016), and
non-linear (Couade et al. 2010) increases in SWV with
blood pressure have been reported. Shih et al. (2018) and
Couade et al. (2010) evaluated the tolerability of this
technique and found that the generated intensities fall
within the guidelines from the Food and Drug Adminis-
tration and there were no histologic changes in the arte-
rial wall after acquisition (Guidelines for Industry and
FDA Staff 2008).
Quantitative stiffness values
As in human studies, quantitative SWE values vary
widely among non-human studies. Additionally, values
between studies are incomparable because the studies
used different setups and analysis methods.
Validation and reproducibility
Stiffness values assessed by SWE were more accu-
rate using phase velocity analysis than group velocity
analysis. Phase velocity-based YM values were in good
agreement with those obtained by mechanical tensile
testing (Widman et al. 2015; He et al. 2017; Guo et al.
2018; Marlevi et al. 2018) (relative and absolute errors
of 8.8 § 6.0% and 5.6 § 4.1 kPa, respectively [Maksuti
et al. 2016]). In cases in which group velocity analysis
was applied, stiffness values were underestimated (Wid-
man et al. 2015; Maksuti et al. 2016; He et al. 2017;
Marlevi et al. 2018), especially in hard plaques (Widman
et al. 2015), although the variance of group velocity-
based stiffness values was smaller (Marlevi et al. 2018).
Group velocity-based SWE had good reproducibil-
ity for YM values (mean inter-frame CV and intra-class
correlation coefficient [ICC] of 1314% and 0.830.84
and mean inter-observer CV and ICC of 0.13 and 0.76,
respectively [Ramnarine et al. 2014a]).
CROSS-SECTIONAL SWE
He et al. (2017) investigated cross-sectional SWE in
a healthy volunteer, an abdominal swine aorta and a
PVA phantom, all without plaques. This study found
that use of cross-sectional SWE was feasible and in good
agreement with mechanical testing in the phantom when
phase velocity analysis was applied. Marlevi et al.
(2020) additionally found that cross-sectional SWE is
able to differentiate vulnerable from stable plaques as
defined by the AHA classification and that SWV corre-
lated with intraplaque components associated with pla-
que vulnerability (i.e., lipid-rich necrotic core content,
fibrous cap/necrotic core volume ratio and intraplaque
hemorrhage volume). Both differentiability and correla-
tions differed between group and phase velocity analysis
settings and between longitudinal and cross-sectional
SWE.
ADDITIONS FROM ABSTRACTS/PROCEEDINGS
Abstracts and proceedings mainly endorse the
results stated above but additionally reported that:
 Tracking of cross-sectional shear wave propagation is
less accurate because the shear wave propagation does
not remain aligned with the ultrasound image lines.
 The shear wave exhibited more dispersive behavior in the
cross-sectional view than in the longitudinal view, possi-
bly because of the curved cross-sectional geometry.
 Imaging is limited in highly calcified plaques because
of acoustic shadowing.
 SWV and mean and median longitudinal-to-trans-
verse SWV ratio are higher in the case of longer statin
therapy (5 vs. <5 y).
 SWV is similar in plaques with and without intrapla-
que neovascularization.
DISCUSSION
To assess the feasibility and diagnostic value of
using SWE in (mimicked) atherosclerotic arteries, a het-
erogeneous collection of studies including human and
non-human patients was included in this systematic
review. All studies reported on the feasibility of using
this technique to assess elasticity in the carotid arterial
wall and plaques separately. Absolute SWE values var-
ied widely among studies, but within each study, statisti-
cally significant differences in elasticity with patient
characteristics were found. US SWE could assess plaque
vulnerability based on histology, symptoms, echogenic-
ity and AHA classification of plaque type. Quantitative
elasticity measurements were in good agreement with
CTA and PWV in human studies and, in cases in which
phase velocity analysis was applied, with mechanical
testing in non-human studies. Good to excellent repro-
ducibility was also reported. A preliminary study on
cross-sectional SWE reported its feasibility.
To our knowledge, only one systematic review was
previously published on vascular SWE using US that
reported results similar to the results in this review. This
review by Mahmood et al. in 2016 evaluated the applica-
bility of US elastography to assessment of carotid artery
plaque vulnerability. Mainly studies using strain were
included; only three articles used SWE in carotid arter-
ies. They concluded that elastography was feasible and
vulnerable plaques mostly had higher strain values. This
corresponds to the lower quantitative stiffness values in
vulnerable plaques found in this review.
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SWE in human studies
Feasibility and value. Higher stiffness values in
the carotid arterial wall with hypertension are expected
because Couade et al. (2010) reported that SWV
increases with higher pressures. However, the higher
stiffness values found in the carotid arterial wall in cases
of Behçet’s disease and in the presence of cardiovascular
risk factors other than hypertension, compared with
healthy controls, may point to the potential of SWE in
assessment of vascular health. However, multiple factors
influence arterial elasticity that have to be considered
when evaluating individuals:
 Personal factors: Age, genetics, blood pressure, heart
rate and different diseases (e.g., diabetes mellitus type
2, cardiovascular and renal disease, pre-eclampsia
[Benetos et al. 2002; Patel et al. 2016] and inflamma-
tory diseases such as rheumatoid arthritis [Mozos
et al. 2017]).
 Lifestyle factors: Exercise, diet (Sacre Julian et al.
2014) and smoking (Patel et al. 2016).
 Extrinsic factors: Medical treatment (e.g., lipid-low-
ering or antihypertensive medication) [Janic et al.
2014], acquisition characteristics (i.e., spatial and
temporal filtering, neck position, pressure applied
with the US probe) [Bamber et al. 2013] and timing
during the cardiac cycle (e.g., arterial diameter
changes resulting from pressure differences within
the cardiac cycle) [Couade et al. 2010].
Changes in arterial stiffness are caused by altera-
tions in structural and functional components of the
artery. These alterations often also cause a change in
IMT, which in itself is one of the key biomarkers of car-
diovascular disease (Yuan et al. 2013).
The lower elasticity values found in hypo-echoic
plaques compared with hyper-echoic plaques might sug-
gest that SWE can identify plaque vulnerability because
several studies found a relation between echogenicity
and plaque vulnerability: (i) histopathology studies
reported more vulnerability features (i.e., more lipid,
less calcification and increased macrophage density) in
hypo-echoic than hyper-echoic plaques (Gronholdt et al.
2002), and (ii) US studies reported a higher prevalence
of future ipsilateral stroke in hypo-echoic than hyper-
echoic plaques over all stenosis severities (stenoses of
099% and >50% are associated with relative risks of
2.31 and 1.62, respectively [Gupta et al. 2015], respec-
tively, and an odds ratio of 3.99 [Brinjikji et al. 2015]).
SWE, however, may be superior to echogenicity in
identifying vulnerable plaques. Echogenicity provides
an indication of plaque composition but does not abso-
lutely assess it, and a poor reproducibility has been
described (Kanber et al. 2013). Care should thus be taken
to correlate echogenicity with plaque vulnerability. The
fact that Garrard et al. (2015) used echogenicity to define
vulnerability may therefore be the reason that only they
did not find a correlation between elasticity and GSM.
The small number of patients (n = 25) and the signifi-
cantly higher proportion of severe stenosis in patients
with unstable plaques (89% vs. 44%) could have influ-
enced the results. Nevertheless, because YM values were
lower in histologic vulnerable plaques, SWE may be
superior to echogenicity in assessing plaque vulnerabil-
ity. This technique’s potential in vulnerability assess-
ment is confirmed by the high sensitivity of SWE in
detection of histologic vulnerable plaques reported by Di
Leo et al. (2018).
The validity of SWE is also emphasized by confer-
ence abstracts that reported lower mean and median lon-
gitudinal-to-transverse SWV ratios and, therefore,
higher stiffness of plaques to be associated with pro-
longed statin therapy. This is expected because stroke
incidence decreases with statin therapy.
Eventually, the correlation between elasticity and
symptomatology is the most important measure because
a CEA would be beneficial in patients with (previous or
future) neurologic symptoms. Therefore, the reported
relationship between symptomatology and lower stiff-
ness values assessed by SWE, further emphasizes this
technique’s potential in improving personalized stroke
risk stratification.
Quantitative stiffness values
Although differences in stiffness values with plaque
vulnerability within each study were statistically signifi-
cant, the high variability between studies needs to be
reduced in the future to establish cutoff values to distin-
guish vulnerable from non-vulnerable plaques. The hetero-
geneity between studies can be caused by multiple study
characteristics. First, by the use of different US machines
as acquisition and post-processing properties differ with the
machine. Alis et al. (2018) reported considerably lower
stiffness values in the arterial wall than the other studies.
They used a Toshiba Aplio 500 machine that does not have
a specific carotid artery mode. Therefore, push location,
assumed propagation trajectory, push moment during car-
diac cycle and amount of spatial and temporal smoothing
were unclear. The remaining human studies used an
Aixplorer (Supersonic Imagine) machine. This system
induces multiple pushes along the beam axis, resulting in
an amplified shear wave strength and a planar shear wave
propagation front (Bamber et al. 2013). It is optimized for
bulk tissues (Couade et al. 2010) and most valid in the
liver. However, vessel stiffness measurements may be inac-
curate with this machine because stiffness is more difficult
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to assess in vessels because they are small, subject to pulsa-
tile motion, anisotropic and of heterogenous composition
(Ramnarine et al. 2014a).
Second, the method of YM calculation may be
responsible. The YM is calculated as YM = 3rc2, where r
= tissue density (in kg/m3), and c is the SWV (in m/s)
(Bamber et al. 2013). However, this formula is accurate
only for incompressible, infinitely large, isotropic and
locally homogeneous material—all characteristics that do
not apply to real arteries. In addition, calculations are per-
formed with an average soft tissue density, whereas the
density is known to vary. Some ultrasound machines
enable the acquisition of raw data that allows use of differ-
ent post-processing techniques to correct for some of these
errors, while most applied scanners display only the calcu-
lated values that cannot be corrected retrospectively.
Third, different areas and locations of analysis were
used. The area of analysis in the clinical scanners ranged
from multiple ROIs of 12 mm to a manually drawn area
around the vascular wall or entire plaque. This, in a differ-
ent manner, accounts for regional stiffness variances.
Fourth, it is important to consider temporal differ-
ences in quantitative values, because SWE values have
been reported to vary between the diastolic (80 § 10
kPa) and systolic (130 § 15 kPa) phases (Couade et al.
2010). Only one human study applied ECG gating to cor-
rect for these differences; all other studies averaged the
SWE values over different frames during the cardiac
cycle, complicating their comparison. SWE with a high
temporal resolution and ECG gating are needed to
improve the comparability between studies.
The high variability in quantitative values between
studies impedes the identification of cutoff values for phys-
iologic or pathologic stiffness in the arterial wall and pla-
ques. Further research with standardized methodology and
improved data analysis might overcome this problem.
Validation and reproducibility
SWE is thought to be more reliable than traditional
ultrasound and PWV in assessing elasticity, which is in
accordance with the good to excellent reproducibility of
SWE described in this review. SWE is less operator and
experience dependent than traditional ultrasound exami-
nation (Lou et al. 2017). Furthermore, SWE would be
more reliable than the frequently used global PWV
(Couade et al. 2010). SWE assesses elasticity directly,
locally and at a user-defined moment during the cardiac
cycle, whereas global PWV assesses elasticity averaged
over a long arterial distance (typically the aorta), which
is in itself already difficult to assess.
Interesting findings by Marais et al. (2019) were the
higher stiffness values and, even more striking, the higher
variance in the posterior than in the anterior arterial wall.
These are important findings because plaques can be
located over the entire wall circumference. The higher vari-
ance in the posterior compared with the anterior wall can
be caused by a lower signal quality because of the larger
distance from the transducer. The larger distance induces
more attenuation and presumably more reflections and
reverberations originating from the overlying soft tissue
(Couade et al. 2010). Another possible cause is the ana-
tomic location of both walls: the anterior wall is located
directly below the jugular vein, but well separated from the
other surrounding tissues, allowing it to move freely; the
posterior wall is directly attached to the muscle layer
beneath it, possibly affecting movement and elasticity to a
greater extent. Also, neck position, and therefore stretch on
the carotid artery, might be a confounding factor (Bamber
et al. 2013). Improved instrumentation and acquisition
parameters (e.g., push depth, resolution and increasing the
energy efficiency of the transducer elements) may over-
come these limitations.
Although it has been reported that SWE provides a
resolution of approximately 0.30 mm2 (Marlevi et al.
2020), to date, in vivo SWE studies have not performed
a regional analysis of plaques but report instead average
shear wave estimates for ROIs encompassing the whole
plaque (12 cm2). Although average values seemed to
correlate with plaque components assessed by MRI
(Marlevi et al. 2020), plaque components might be better
distinguished with regional analyses, especially in pla-
ques with mixed compositions.
Studies in non-human patients
Feasibility and tolerability. Non-human studies
evaluated the tolerability of SWE, but more research is
needed to make a definite assessment. The main concern
in SWE application is the possibility of plaque rupture
caused by the induced push, although Doherty et al.
(2013) found that stress induced by the ARFI push pulse
was three orders of magnitude lower than stress induced
by the blood pressure. Additional studies in human pla-
ques are required to definitely assess the influence of
SWE on plaque rupture.
Validation and reproducibility. In clinical practice,
elasticity is assessed using group velocity analysis, but
absolute values assessed using phase velocity analysis
might be more accurate, especially for stiffer plaques, as
non-human studies have reported more accurate stiffness
values in the latter case. Dispersion, which is not taken into
account in group velocity analysis, probably causes this dif-
ference. Dispersion is a result of tissue viscosity, which has
also been reported in PVA when measured with atomic
force microscopy (Yang et al. 2009), and of the confined
geometry of the vessel wall that strongly affects shear
wave propagation. The wavelengths of the shear waves
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generated are in the range of millimeters, similar to phan-
tom or vessel thickness. Internal reflections at the
medium’s boundaries do, therefore, strongly affect their
propagation. Exact geometry becomes less important at
higher frequencies (>1000 Hz) because the shear wave
wavelength becomes smaller compared with the wall thick-
ness (Couade et al. 2010). However, with higher frequen-
cies, there is also more attenuation. A trade-off between
wavelength and attenuation must therefore be made.
Imaging settings. Most non-human studies were
performed to evaluate new mathematical models or data
processing techniques, giving rise to recommendations
regarding SWE acquisitions. To accurately assess elas-
ticity values, non-human studies emphasize that:
 High-frequency bandwidths, that is, including fre-
quencies greater than 1 kHz (Couade et al. 2010; Mar-
levi et al. 2018) or 1.5 kHz (Widman et al. 2016),
need to be excited because of the dispersion phenome-
non resulting from the confined geometry that occurs
at lower frequencies.
 A high pulse repetition frequency (PRF) is needed to
accurately assess SWV, especially in tissues subject
to high pressure or with higher stiffness. Because the
shear wave travels faster in these tissues, a higher
PRF is needed to acquire the same number of images
of the shear wave and, therefore, to assess the SWV
with the same accuracy. A high PRF is even more
important than image quality (Widman et al. 2016).
 The optimal push location needs to be chosen.
Although the SWV estimation does not change with
push location, different push locations are associated
with changes in signal-to-noise ratio and maximum
particle velocity (Marlevi et al. 2018).
 The geometry of the vessel is dependent on the acqui-
sition angle (e.g., the angle with respect to the longitu-
dinal direction of the vessel). In some cases, this
view-dependent altered geometry can cause overesti-
mation of YM, so a correction for an induced differ-
ence in geometry needs to be applied (Guo et al.
2018).
Non-human studies also underline the influence of
pressure differences on stiffness values and, therefore,
the necessity to assess stiffness at a precise time within
the cardiac cycle. Arterial wall stiffness increases when
arterial pressure increases. Therefore, stiffness values
will vary with blood pressure and pressure differences
throughout the cardiac cycle. The fact that this response
between stiffness and pressure is reported to be both lin-
ear and non-linear by different studies could be
explained by the elastincollagen model. In case of low
stress (blood pressure <100 mm Hg) elastin fibers will
stiffen the artery with increasing pressure. In case of
higher stress (blood pressure >100 mm Hg), when elas-
tin fibers are already fully stressed, collagen fibers are
recruited for the stiffening of the arteries (Callaghan
et al. 1986). Because the two types of fibers have differ-
ent mechanical properties, their elasticity does not
respond identically to changes in stress.
Cross-sectional SWE
Combining longitudinal and cross-sectional SWE
might improve the accuracy of SWE. Because of the
anisotropy of vessel walls (Shcherbakova et al. 2015),
longitudinal measurements cannot completely evaluate
elasticity along the arterial circumference. Additionally,
not all plaques can be imaged optimally in the longitudi-
nal direction because they may also be located on the
side walls of the artery. Eccentrically located plaques
have even been associated with a significantly increased
incidence of ipsilateral cerebrovascular events in large
clinical trials (Ohara et al. 2008).
Cross-sectional SWE can overcome this limitation
and has successfully been applied in the carotid arterial
wall (Hansen et al. 2015; He et al. 2017; Marlevi et al.
2020) but remains challenging. Difficulties in propaga-
tion tracking caused by fast attenuation and the failure of
the particle motion resulting from shear wave propaga-
tion to remain aligned with the ultrasound image lines
need to be overcome before it can be clinically imple-
mented.
Limitations
This systematic review has several limitations.
First, the heterogeneity of the included studies in terms
of study type (i.e., in vivo, ex vivo or in vitro), disease
characteristics, number of patients, applied ultrasound
machines and settings, number of measurements, push
location, methods of comparison, and type of reported
data. This heterogeneity markedly hampers comparison
between different studies. Second, only a small number
of patients and a relatively small number of human stud-
ies have been published. Moreover, only one study was
performed prospectively, and no follow-up studies were
performed. Additionally, plaques are usually evaluated
after a cardiovascular event is detected. Therefore, stiff-
ness before the CEA is unknown, although this would
probably be a more important measure for stroke risk
stratification.
Although studies in non-human patients mimic the
situation in human arteries, there are multiple concerns
over the applicability of these studies in humans in vivo.
In contrast to PVA phantoms, real vessels are more het-
erogeneous with multiple layers with different elasticity
(Shcherbakova et al. 2015), are anisotropic (Chai et al.
2013; Shcherbakova et al. 2015), often contain
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calcifications causing shadowing, are viscoelastic and
have been considered compressible and incompressible
in conflicting studies (Yosibash et al. 2014). Further-
more, most studies were performed in water, while in
vivo carotid arteries are surrounded by other attenuating
tissues such as muscles, fat, veins and nerves.
Further research, ideally large, longitudinal, pro-
spective clinical studies in patients before and after
symptom occurrence in a longitudinal and circumferen-
tial direction, including histologic evaluation, is needed
to better evaluate this technique’s prognostic accuracy,
reproducibility and quantitative value.
CONCLUSIONS
This systematic review focused on the feasibility of
US SWE in vascular applications and its ability to con-
tribute to plaque characterization. Ischemic strokes are
widespread, highly immobilizing conditions, so risk
stratification is very important. However, current clinical
practice remains suboptimal. To improve this situation,
this systematic review aimed to investigate the feasibility
and diagnostic value of vascular US SWE in (mimicked)
arteries affected by different stages of atherosclerotic
disease or diseases related to atherosclerosis, to eventu-
ally develop a more personalized stroke risk stratifica-
tion. All studies reported the feasibility of using SWE
(quantitatively) to assess stiffness of the arterial wall and
plaques and to assess plaque vulnerability based on
echogenicity, symptomatology and histology with good
to excellent reproducibility. These findings confirm its
potential to improve stroke risk stratification. However,
further technical and clinical research is needed to opti-
mize and standardize its performance and to explore and
confirm its true diagnostic value.
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